SlideShare une entreprise Scribd logo
1  sur  15
Ruling out using ABID Panel Please print Antibody Panel 1 It will be helpful to have
Panocell for ABID
ABID Look at the panel and check Phases that have positive reactions Phase that do not have positive reactions Are there different reaction strengths recorded? Are there reactions at different  phases? Patient auto control Is it negative or positive? These are all clues to help with identification
Look for Clues 1 Reactions are all at AGH Reaction strength is different at cell 3 Different reaction strengths can indicate:  dosage and/or multiple antibodies Patient auto control is negative, indicating a possible alloantibody
Begin Ruling Out Use only panel cells that have no reaction recorded in any phase. Begin with cell #2 Follow with cells #5 and #6 What is left?
Ruling Out When ruling out  Use only cells where no reaction is recorded Go one cell at a time and mark out antigens that are positive Watch out for antigens that show dosage Kidd, Kell, Duffy, MNS, Lewis If both are present on the cell then can not be ruled out Look for a pattern to show up especially if only one antibody is present in patient serum
Lets begin! The first cell with a negative reaction is panel cell 2. Go across cell 2 and mark out all antigens that are positive.
Panel Red Cell #2 All positive antigens for panel cell #2 have been marked out except for M and N. M and N travel together and therefore show dosage.    In order to mark out antigens showing dosage, one antigen must be positive       and the other negative.
Continue Ruling out Antigens Continue ruling out Use only panels cells where no reaction occurred After all antigens are marked out look and see what is left.
What is left? After ruling out: Check what antigens are not marked out In our example Antigen s and K are not marked out What are we testing for? Patient serum/plasma for unexpected antibodies Antibodies react with:  antigens on red cells Consider the Rule of Three when interpreting results
Rule Of Three There must be three antigens that react positively with the patients serum/plasma. There must be Three antigens that react negatively with the patients serum/plasma. If not, use selected cells with or without the antigen in question to meet the Rule of Three
What About our Example? Antigen K –  Meets the rule of three Does not match the reaction pattern Cannot rule out yet Antigen s – Meets the rule of three Does match the reaction pattern Cannot rule out yet
How to Resolve  Phenotype the patient red cells for antigen K and s If patient is negative for the antigen then the antibody could be present If patient is positive for the antigen then the reactions would not be from the corresponding antibody
Patient Phenotype The patient is positive for the K antigen; therefore will not make Anti-K. (Remember Landsteiner’s Rule!) The patient is negative for the s antigen; therefore the antibody is most likely Anti-s
Interpretation of Results Based on the panel reactions and the antigen test results: 		Our patient has a possible anti-s in his 	serum/plasma. When you get a chance, ask if you might review some panels at your clinical site.

Contenu connexe

Tendances

Pre transfusion testing, dr. rafiq
Pre transfusion testing, dr. rafiqPre transfusion testing, dr. rafiq
Pre transfusion testing, dr. rafiq
Rafiq Ahmad
 
20140430l北捐auto anibody
20140430l北捐auto anibody20140430l北捐auto anibody
20140430l北捐auto anibody
Jhysheng Chang
 
Transfusion pathology
Transfusion pathologyTransfusion pathology
Transfusion pathology
raj kumar
 
Blood typing analysis
Blood typing analysisBlood typing analysis
Blood typing analysis
zs4033bn
 
3.inmuno hematología.inmunologia.2011.dr hilario
3.inmuno   hematología.inmunologia.2011.dr hilario3.inmuno   hematología.inmunologia.2011.dr hilario
3.inmuno hematología.inmunologia.2011.dr hilario
Joseph Polo Mejia
 
Blood typing analysis
Blood typing analysisBlood typing analysis
Blood typing analysis
mv4428bn
 
Blood typing analysis
Blood typing analysisBlood typing analysis
Blood typing analysis
gentrybeard
 

Tendances (20)

Pre transfusion testing, dr. rafiq
Pre transfusion testing, dr. rafiqPre transfusion testing, dr. rafiq
Pre transfusion testing, dr. rafiq
 
Coomb's test and a case history by darshika taran
Coomb's test and a case history by darshika taranCoomb's test and a case history by darshika taran
Coomb's test and a case history by darshika taran
 
20140430l北捐auto anibody
20140430l北捐auto anibody20140430l北捐auto anibody
20140430l北捐auto anibody
 
Transfusion reactions
Transfusion reactionsTransfusion reactions
Transfusion reactions
 
Forward and reverse grouping by Negash Alamin
Forward and reverse grouping  by Negash AlaminForward and reverse grouping  by Negash Alamin
Forward and reverse grouping by Negash Alamin
 
Blood grouping and Cross matching
Blood grouping and Cross matchingBlood grouping and Cross matching
Blood grouping and Cross matching
 
Cross matching
Cross matchingCross matching
Cross matching
 
Blood Banking
Blood BankingBlood Banking
Blood Banking
 
Screening for diseases transmitted through blood
Screening for diseases transmitted through bloodScreening for diseases transmitted through blood
Screening for diseases transmitted through blood
 
Basics of immunohematology - copy
Basics of immunohematology - copyBasics of immunohematology - copy
Basics of immunohematology - copy
 
Gel tech
Gel techGel tech
Gel tech
 
Transfusion pathology
Transfusion pathologyTransfusion pathology
Transfusion pathology
 
ABO Blood Grouping
ABO Blood GroupingABO Blood Grouping
ABO Blood Grouping
 
Blood typing analysis
Blood typing analysisBlood typing analysis
Blood typing analysis
 
Compatibility testing
Compatibility testingCompatibility testing
Compatibility testing
 
3.inmuno hematología.inmunologia.2011.dr hilario
3.inmuno   hematología.inmunologia.2011.dr hilario3.inmuno   hematología.inmunologia.2011.dr hilario
3.inmuno hematología.inmunologia.2011.dr hilario
 
Immunohematology
ImmunohematologyImmunohematology
Immunohematology
 
Blood typing analysis
Blood typing analysisBlood typing analysis
Blood typing analysis
 
Blood typing analysis
Blood typing analysisBlood typing analysis
Blood typing analysis
 
Bloob grouping and
Bloob grouping andBloob grouping and
Bloob grouping and
 

En vedette (8)

Creating a uc strategy
Creating a uc strategyCreating a uc strategy
Creating a uc strategy
 
Flow Cytometry Training: Introduction day 1 session 2
Flow Cytometry Training: Introduction day 1 session 2Flow Cytometry Training: Introduction day 1 session 2
Flow Cytometry Training: Introduction day 1 session 2
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Cyto 2015 Forensic Flow Cytometry Tutorial
Cyto 2015 Forensic Flow Cytometry TutorialCyto 2015 Forensic Flow Cytometry Tutorial
Cyto 2015 Forensic Flow Cytometry Tutorial
 
Ag ab reactions and clinical utility
Ag ab reactions and clinical utilityAg ab reactions and clinical utility
Ag ab reactions and clinical utility
 
Rh Blood Group System
Rh Blood Group SystemRh Blood Group System
Rh Blood Group System
 
Week 8 Observation and Analysis
Week 8 Observation and AnalysisWeek 8 Observation and Analysis
Week 8 Observation and Analysis
 
Immunoassay systems
Immunoassay systemsImmunoassay systems
Immunoassay systems
 

Similaire à Ruling out using abid panel

cgallagherNtr5502project
cgallagherNtr5502projectcgallagherNtr5502project
cgallagherNtr5502project
corypgallagher
 
BIOTECHNOLOGY 2 Lecture 9 ELISA TEST.pptx
BIOTECHNOLOGY 2 Lecture 9 ELISA TEST.pptxBIOTECHNOLOGY 2 Lecture 9 ELISA TEST.pptx
BIOTECHNOLOGY 2 Lecture 9 ELISA TEST.pptx
ZeljkoPopovic8
 
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASESLABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
Sadd Alias
 
Allergy Clinic Final Brochure
Allergy Clinic Final BrochureAllergy Clinic Final Brochure
Allergy Clinic Final Brochure
Daniel Harper
 

Similaire à Ruling out using abid panel (20)

antibody identification ppt.ppt
antibody identification ppt.pptantibody identification ppt.ppt
antibody identification ppt.ppt
 
Antigen and immunogens, types and mitogens .ppt
Antigen and immunogens, types and mitogens .pptAntigen and immunogens, types and mitogens .ppt
Antigen and immunogens, types and mitogens .ppt
 
Crossmatching
CrossmatchingCrossmatching
Crossmatching
 
crossmatching.pptx
crossmatching.pptxcrossmatching.pptx
crossmatching.pptx
 
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) .pptx
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) .pptxENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) .pptx
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) .pptx
 
Elisa 1 copy.ppt
Elisa 1   copy.pptElisa 1   copy.ppt
Elisa 1 copy.ppt
 
ABO Blood Group System.pptx
ABO  Blood Group System.pptxABO  Blood Group System.pptx
ABO Blood Group System.pptx
 
cgallagherNtr5502project
cgallagherNtr5502projectcgallagherNtr5502project
cgallagherNtr5502project
 
ELISA TEST.pptx
ELISA TEST.pptxELISA TEST.pptx
ELISA TEST.pptx
 
BIOTECHNOLOGY 2 Lecture 9 ELISA TEST.pptx
BIOTECHNOLOGY 2 Lecture 9 ELISA TEST.pptxBIOTECHNOLOGY 2 Lecture 9 ELISA TEST.pptx
BIOTECHNOLOGY 2 Lecture 9 ELISA TEST.pptx
 
Bioassay
BioassayBioassay
Bioassay
 
ELISA Presentation.ppt
ELISA Presentation.pptELISA Presentation.ppt
ELISA Presentation.ppt
 
Radioimmunoassay and related immunoassay techniques
Radioimmunoassay and related immunoassay techniquesRadioimmunoassay and related immunoassay techniques
Radioimmunoassay and related immunoassay techniques
 
Determination of blood group
Determination of blood groupDetermination of blood group
Determination of blood group
 
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASESLABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
LABORATORY INVESTIGATION OF TRANSFUSION REACTION CASES
 
coombs test
coombs testcoombs test
coombs test
 
Allergy Clinic Final Brochure
Allergy Clinic Final BrochureAllergy Clinic Final Brochure
Allergy Clinic Final Brochure
 
Elisa test
Elisa testElisa test
Elisa test
 
Elisa test
Elisa testElisa test
Elisa test
 
Antigen antibody reactions
Antigen antibody reactionsAntigen antibody reactions
Antigen antibody reactions
 

Dernier

IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI Solutions
Enterprise Knowledge
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
Joaquim Jorge
 

Dernier (20)

Handwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed textsHandwritten Text Recognition for manuscripts and early printed texts
Handwritten Text Recognition for manuscripts and early printed texts
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
🐬 The future of MySQL is Postgres 🐘
🐬  The future of MySQL is Postgres   🐘🐬  The future of MySQL is Postgres   🐘
🐬 The future of MySQL is Postgres 🐘
 
Automating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps ScriptAutomating Google Workspace (GWS) & more with Apps Script
Automating Google Workspace (GWS) & more with Apps Script
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Tech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdfTech Trends Report 2024 Future Today Institute.pdf
Tech Trends Report 2024 Future Today Institute.pdf
 
IAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI SolutionsIAC 2024 - IA Fast Track to Search Focused AI Solutions
IAC 2024 - IA Fast Track to Search Focused AI Solutions
 
Artificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and MythsArtificial Intelligence: Facts and Myths
Artificial Intelligence: Facts and Myths
 
GenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day PresentationGenCyber Cyber Security Day Presentation
GenCyber Cyber Security Day Presentation
 
Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024Partners Life - Insurer Innovation Award 2024
Partners Life - Insurer Innovation Award 2024
 
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
08448380779 Call Girls In Diplomatic Enclave Women Seeking Men
 
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...Workshop - Best of Both Worlds_ Combine  KG and Vector search for  enhanced R...
Workshop - Best of Both Worlds_ Combine KG and Vector search for enhanced R...
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
 
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
04-2024-HHUG-Sales-and-Marketing-Alignment.pptx
 
Boost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdfBoost Fertility New Invention Ups Success Rates.pdf
Boost Fertility New Invention Ups Success Rates.pdf
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 

Ruling out using abid panel

  • 1. Ruling out using ABID Panel Please print Antibody Panel 1 It will be helpful to have
  • 3. ABID Look at the panel and check Phases that have positive reactions Phase that do not have positive reactions Are there different reaction strengths recorded? Are there reactions at different phases? Patient auto control Is it negative or positive? These are all clues to help with identification
  • 4. Look for Clues 1 Reactions are all at AGH Reaction strength is different at cell 3 Different reaction strengths can indicate: dosage and/or multiple antibodies Patient auto control is negative, indicating a possible alloantibody
  • 5. Begin Ruling Out Use only panel cells that have no reaction recorded in any phase. Begin with cell #2 Follow with cells #5 and #6 What is left?
  • 6. Ruling Out When ruling out Use only cells where no reaction is recorded Go one cell at a time and mark out antigens that are positive Watch out for antigens that show dosage Kidd, Kell, Duffy, MNS, Lewis If both are present on the cell then can not be ruled out Look for a pattern to show up especially if only one antibody is present in patient serum
  • 7. Lets begin! The first cell with a negative reaction is panel cell 2. Go across cell 2 and mark out all antigens that are positive.
  • 8. Panel Red Cell #2 All positive antigens for panel cell #2 have been marked out except for M and N. M and N travel together and therefore show dosage. In order to mark out antigens showing dosage, one antigen must be positive and the other negative.
  • 9. Continue Ruling out Antigens Continue ruling out Use only panels cells where no reaction occurred After all antigens are marked out look and see what is left.
  • 10. What is left? After ruling out: Check what antigens are not marked out In our example Antigen s and K are not marked out What are we testing for? Patient serum/plasma for unexpected antibodies Antibodies react with: antigens on red cells Consider the Rule of Three when interpreting results
  • 11. Rule Of Three There must be three antigens that react positively with the patients serum/plasma. There must be Three antigens that react negatively with the patients serum/plasma. If not, use selected cells with or without the antigen in question to meet the Rule of Three
  • 12. What About our Example? Antigen K – Meets the rule of three Does not match the reaction pattern Cannot rule out yet Antigen s – Meets the rule of three Does match the reaction pattern Cannot rule out yet
  • 13. How to Resolve Phenotype the patient red cells for antigen K and s If patient is negative for the antigen then the antibody could be present If patient is positive for the antigen then the reactions would not be from the corresponding antibody
  • 14. Patient Phenotype The patient is positive for the K antigen; therefore will not make Anti-K. (Remember Landsteiner’s Rule!) The patient is negative for the s antigen; therefore the antibody is most likely Anti-s
  • 15. Interpretation of Results Based on the panel reactions and the antigen test results: Our patient has a possible anti-s in his serum/plasma. When you get a chance, ask if you might review some panels at your clinical site.